Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

RISEDRONATE SODIUM Drug Profile

« Back to Dashboard

Which patents cover Risedronate Sodium, and what generic Risedronate Sodium alternatives are available?

Risedronate Sodium is a drug marketed by Teva Pharms Usa, Macleods Pharms Ltd, Aurobindo Pharma Ltd, Apotex Inc, Mylan Pharms Inc, and Sun Pharma Global. and is included in nine NDAs.

The generic ingredient in RISEDRONATE SODIUM is risedronate sodium. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the risedronate sodium profile page.

Summary for Tradename: RISEDRONATE SODIUM

Patents:0
Applicants:6
NDAs:9
Suppliers / Packagers: see list7
Bulk Api Vendors: see list125
Clinical Trials: see list953
Patent Applications: see list3,042
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RISEDRONATE SODIUM at DailyMed

Pharmacology for Tradename: RISEDRONATE SODIUM

Ingredient-typeDiphosphonates
Drug ClassBisphosphonate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
RISEDRONATE SODIUM
risedronate sodium
TABLET;ORAL079215-001Jun 13, 2014ABRXNoNo► Subscribe► Subscribe
Sun Pharma Global
RISEDRONATE SODIUM
risedronate sodium
TABLET;ORAL090886-001Nov 30, 2015ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
RISEDRONATE SODIUM
risedronate sodium
TABLET;ORAL200296-002Nov 30, 2015ABRXNoNo► Subscribe► Subscribe
Macleods Pharms Ltd
RISEDRONATE SODIUM
risedronate sodium
TABLET;ORAL203533-002Dec 9, 2015ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
RISEDRONATE SODIUM
risedronate sodium
TABLET;ORAL077132-002Oct 5, 2007ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot